Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ · Healthcare
Ionis Pharmaceuticals, Inc. Revenue 2008–2025
Ionis Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2008 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Ionis Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 246.1 M, a 86.98% increase year-over-year.
- Ionis Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 986.5 M, a 58.40% increase year-over-year.
- Ionis Pharmaceuticals, Inc. annual revenue for 2025 was 943.7 M, a 33.83% increase from 2024.
- Ionis Pharmaceuticals, Inc. annual revenue for 2024 was 705.1 M, a 10.48% decrease from 2023.
- Ionis Pharmaceuticals, Inc. annual revenue for 2023 was 787.6 M, a 34.10% increase from 2022.
- Ionis Pharmaceuticals, Inc. annual revenue for 2022 was 587.4 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ionis Pharmaceuticals, Inc. Market Cap — FAQ
Ionis Pharmaceuticals, Inc. (IONS) market cap over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IONS's market cap history?
The chart and table above show Ionis Pharmaceuticals, Inc.'s market cap by year and by quarter, including the growth rate.